Viewing Study NCT02180451


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-02-25 @ 9:49 PM
Study NCT ID: NCT02180451
Status: UNKNOWN
Last Update Posted: 2016-03-25
First Post: 2014-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)
Sponsor: Vanda Pharmaceuticals
Organization:

Study Overview

Official Title: Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)
Status: UNKNOWN
Status Verified Date: 2016-03
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to characterize the circadian rhythm disruption experienced by patients as determined by plasma melatonin, cortisol, and other circadian analytes
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: